Tian H - Search Results

1

Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy.

Li K, Tian H. Li K, et al. Among authors: tian h. J Drug Target. 2019 Mar;27(3):244-256. doi: 10.1080/1061186X.2018.1440400. Epub 2018 Feb 20. J Drug Target. 2019. PMID: 29448849 Review.

2

Current Development Status of MEK Inhibitors.

Cheng Y, Tian H. Cheng Y, et al. Among authors: tian h. Molecules. 2017 Sep 26;22(10):1551. doi: 10.3390/molecules22101551. Molecules. 2017. PMID: 28954413 Free PMC article. Review.

3

Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations.

Miao L, Tian H. Miao L, et al. Among authors: tian h. J Drug Target. 2020 Feb;28(2):154-165. doi: 10.1080/1061186X.2019.1648477. Epub 2019 Aug 13. J Drug Target. 2020. PMID: 31340679 Review.

4

1,4-Dithiothreitol treatment ameliorates hematopoietic and intestinal injury in irradiated mice: Potential application of a treatment for acute radiation syndrome.

Li K, Zhang J, Cao J, Li X, Tian H. Li K, et al. Among authors: tian h. Int Immunopharmacol. 2019 Nov;76:105913. doi: 10.1016/j.intimp.2019.105913. Epub 2019 Oct 15. Int Immunopharmacol. 2019. PMID: 31627170

5

Renoprotective Effects of a New Free Radical Scavenger, XH-003, against Cisplatin-Induced Nephrotoxicity.

Liu YH, Li K, Tian HQ. Liu YH, et al. Oxid Med Cell Longev. 2020 Apr 18;2020:9820168. doi: 10.1155/2020/9820168. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32377314 Free PMC article.

6

Polycysteine as a new type of radio-protector ameliorated tissue injury through inhibiting ferroptosis in mice.

Zhang J, Li K, Zhang Q, Zhu Z, Huang G, Tian H. Zhang J, et al. Among authors: tian h. Cell Death Dis. 2021 Feb 18;12(2):195. doi: 10.1038/s41419-021-03479-0. Cell Death Dis. 2021. PMID: 33602915 Free PMC article.

7

A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer.

Cheng Y, Wang X, Xia X, Zhang W, Tian H. Cheng Y, et al. Among authors: tian h. Int J Cancer. 2019 Jul 15;145(2):586-596. doi: 10.1002/ijc.32119. Epub 2019 Jan 28. Int J Cancer. 2019. PMID: 30628057

8

Metal-Organic Framework (MOF)-Based Drug Delivery.

Cao J, Li X, Tian H. Cao J, et al. Among authors: tian h. Curr Med Chem. 2020;27(35):5949-5969. doi: 10.2174/0929867326666190618152518. Curr Med Chem. 2020. PMID: 31215374 Review.

9

Preclinical Evaluation of Safety, Pharmacokinetics, Efficacy, and Mechanism of Radioprotective Agent HL-003.

Liu Y, Miao L, Guo Y, Tian H. Liu Y, et al. Among authors: tian h. Oxid Med Cell Longev. 2021 Feb 19;2021:6683836. doi: 10.1155/2021/6683836. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33688393 Free PMC article.

10

Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.

Liu N, Wang Y, Huang G, Ji C, Fan W, Li H, Cheng Y, Tian H. Liu N, et al. Among authors: tian h. Bioorg Chem. 2016 Apr;65:146-58. doi: 10.1016/j.bioorg.2016.02.009. Epub 2016 Mar 2. Bioorg Chem. 2016. PMID: 26950400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,958 results

Search Page

Filters